Pre-IPO Pharma

[Pre-IPO Pharma @preipopharma]

Wugen to Present Data on WU-NK-101 at the American Association for Cancer Research (AACR) Annual Meeting 2023 https://t.co/fPU7rlfM7U #preIPO #biotech #pharmaceuticals

[Pre-IPO Pharma @preipopharma]

Transcenta's Osemitamab (TST001) Targeting Claudin18.2 Granted Orphan Drug Designation for Treatment of Pancreatic Cancer https://t.co/xm1lXDg0IO #preIPO #biotech #pharmaceuticals

[Pre-IPO Pharma @preipopharma]

Boehringer Ingelheim reaches more patients than ever in 2022 as innovative medicines drive growth https://t.co/xyFGl2pyyI #preIPO #biotech #pharmaceuticals

[Pre-IPO Pharma @preipopharma]

Lucy Therapeutics Appoints Neuroscience Drug Discovery and Development Expert Christopher J. Winrow, Ph.D., as Chief Scientific Officer https://t.co/IhN3vzVQuH #preIPO #biotech #pharmaceuticals

[Pre-IPO Pharma @preipopharma]

Henry Gosebruch, Former AbbVie EVP and Chief Strategy Officer, Joins ACELYRIN, INC. Board of Directors https://t.co/ojsHlFGmzt #preIPO #biotech #pharmaceuticals

[Pre-IPO Pharma @preipopharma]

Juno Pharmaceuticals receives approval to import Eptifibatide as Canadian hospitals continue to grapple with shortages of critical medicines https://t.co/Wlgwfd32Vx #preIPO #biotech #pharmaceuticals

[Pre-IPO Pharma @preipopharma]

Spiral Therapeutics Acquires Otonomy Assets to Boost Inner Ear Disorders Pipeline and Appoints Industry Leaders to Board https://t.co/ugrGXrQFOT #preIPO #biotech #pharmaceuticals

[Pre-IPO Pharma @preipopharma]

Switch Therapeutics Expands Leadership Team with Key Appointments https://t.co/Agnh5jLr3n #preIPO #biotech #pharmaceuticals

[Pre-IPO Pharma @preipopharma]

Sonoma Biotherapeutics and Regeneron Announce Collaboration to Discover, Develop and Commercialize Treg Cell Therapies for Autoimmune Diseases https://t.co/oyHbQhlUQg #preIPO #biotech #pharmaceuticals

[Pre-IPO Pharma @preipopharma]

Salubris Biotherapeutics Announces $35 Million Financing to Advance Development Activities and Provides Pipeline Updates https://t.co/MuraqqxMEj #preIPO #biotech #pharmaceuticals

[Pre-IPO Pharma @preipopharma]

Salipro Biotech publishes research in Scientific Reports on structure-function studies for membrane proteins in collaboration with AstraZeneca https://t.co/yIGXNVBEpA #preIPO #biotech #pharmaceuticals

[Pre-IPO Pharma @preipopharma]

Ratio Therapeutics Announces Licensing Agreement for Investigational PET Imaging Agent with Merck https://t.co/MlCPIzxfQd #preIPO #biotech #pharmaceuticals

[Pre-IPO Pharma @preipopharma]

Prilenia Achieves Last Patient Last Visit in Phase 3 PROOF-HD Clinical Study for Huntington’s Disease https://t.co/dJ5unYDKHa #preIPO #biotech #pharmaceuticals

[Pre-IPO Pharma @preipopharma]

Osivax Awarded Grant from a Leading Non-Governmental Organization for OVX836, its Broad-Spectrum Influenza Vaccine https://t.co/vORTUNeBM3 #preIPO #biotech #pharmaceuticals

[Pre-IPO Pharma @preipopharma]

Grey Wolf Therapeutics Announces Dosing of First Patient in Phase 1/2 Clinical Study of GRWD5769 in Patients with Advanced Solid Tumours USA - English APAC - English https://t.co/OKFHwpqSAf #preIPO #biotech #pharmaceuticals

[Pre-IPO Pharma @preipopharma]

Direct Biologics Announces First Patient Dosed with ExoFlo™ in a Phase 1 Clinical Trial for Medically Refractory Ulcerative Colitis https://t.co/er0rFGgFVL #preIPO #biotech #pharmaceuticals

[Pre-IPO Pharma @preipopharma]

Bryn Pharma’s UTULY™ 13.2mg Intranasal Epinephrine Spray Provides Enhanced PK Profile (higher and more sustained) Compared to 0.3mg Epinephrine Autoinjector (EpiPen) in Subjects with and without Nasal Conges... https://t.co/qwqlqxB305 #preIPO #biotech #pharmaceuticals

[Pre-IPO Pharma @preipopharma]

NEURELIS ANNOUNCES FIRST HEALTHY SUBJECTS DOSED IN INVESTIGATIONAL STUDY OF NRL-1049, A RHO KINASE (ROCK) INHIBITOR WITH POTENTIAL TO TREAT CEREBRAL CAVERNOUS MALFORMATIONS https://t.co/UdqYFLabfu #preIPO #biotech #pharmaceuticals

[Pre-IPO Pharma @preipopharma]

ReCode Therapeutics to Present at Guggenheim Healthcare Talks: Genomic Medicines and Rare Disease Days https://t.co/l0Ysp55sDr #preIPO #biotech #pharmaceuticals

[Pre-IPO Pharma @preipopharma]

Seismic Therapeutic Appoints Melanie Manning as Chief People Officer https://t.co/WIfiIGD4mW #preIPO #biotech #pharmaceuticals